Skip to search.
 TSX Down 0.74% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Gilead Sciences Inc. (GILD)

-NasdaqGS

55.48 May 23, 4:00PM EDT|Pre-Market : 55.43 Down 0.05 (0.09%) 9:00AM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:55.48
Open:N/A
Bid:55.31 x 500
Ask:55.43 x 300
1y Target Est:64.54
Beta:0.81
Next Earnings Date:22-Jul-13GILD Earnings announcement
Day's Range:N/A - N/A
52wk Range:24.12 - 58.06
Volume:3,407
Avg Vol (3m):11,915,900
Market Cap:84.63B
P/E (ttm):31.06
EPS (ttm):1.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
GILD 0.00%84.63B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.73%11.97B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):19.13
P/S (ttm):8.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :1.97
Quarterly EPS Est (Jun-13) :0.49
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback